DEANNA GEISLER: Open Payments
NPI 1851622542 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,639 in 139 payments from 20 companies in 2025. Trend: 2023 $2,289 · 2024 $2,478 · 2025 $2,639
Food & beverage: $2,539Education: $100
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 22 | $366 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $314 |
| Galderma Laboratories, L.P. | 14 | $259 |
| ABBVIE INC. | 20 | $234 |
| GENZYME CORPORATION | 9 | $216 |
| Regeneron Healthcare Solutions, Inc. | 9 | $214 |
| Novartis Pharmaceuticals Corporation | 10 | $187 |
| Janssen Biotech, Inc. | 11 | $185 |
| UCB, Inc. | 5 | $103 |
| Lilly USA, LLC | 5 | $94 |
Products named: DUPIXENT, ADBRY, ILUMYA, TREMFYA, ANZUPGO, NEMLUVIO, COSENTYX, SKYRIZI.
Industry payments across MI — which companies pay providers there.
